Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Amarin Pharma Inc patents


Recent patent applications related to Amarin Pharma Inc. Amarin Pharma Inc is listed as an Agent/Assignee. Note: Amarin Pharma Inc may have other listings under different names/spellings. We're not affiliated with Amarin Pharma Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Amarin Pharma Inc-related inventors


Methods of treating pediatric metabolic syndrome

In various embodiments, the present invention provides methods of treating and/or preventing pediatric metabolic syndrome comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.. . ... Amarin Pharma Inc

Methods of treating or preventing prostate cancer

In various embodiments, the present invention provides methods of treating and/or preventing prostate cancer and, in particular, the method comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.. . ... Amarin Pharma Inc

Compositions and methods for lowering levels of high-sensitivity c-reactive protein (hs-crp) in a subject

The present disclosure provides methods for treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. In some embodiments, the method comprises lowering high sensitivity crp (hs-crp) levels in a subject including, for example, a subject with a hba1c value of about 5.00%-8.50% or at least about 6.8%.. ... Amarin Pharma Inc

Methods of treating mixed dyslipidemia

The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with ethyl eicosapentaenoate.. . ... Amarin Pharma Inc

Methods of reducing or preventing oxidative modification of membrane polyunsaturated fatty acids

In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of reducing or preventing membrane cholesterol domain formation in a subject, the method comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.. . ... Amarin Pharma Inc

Co-administration of atorvastatin and ethyl eicosapentaenoic acid or a derivative thereof

In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of reducing triglycerides in a subject on atorvastatin therapy, the method comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof. . ... Amarin Pharma Inc

Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids

In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of reducing or preventing sdldl oxidation in a subject, the method comprising administering to the subject a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.. . ... Amarin Pharma Inc

Methods of reducing the risk of a cardiovascular event in a subject on statin therapy

In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, a method of reducing the risk of a cardiovascular event in a subject on statin therapy having a fasting baseline triglyceride level of about 135 mg/dl to about 500 mg/dl, and administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.. . ... Amarin Pharma Inc

Methods of reducing the risk of a cardiovascular event in a subject on statin therapy

In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, a method of reducing the risk of a cardiovascular event in a subject on statin therapy having a fasting baseline triglyceride level of about 135 mg/dl to about 500 mg/dl, and administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.. . ... Amarin Pharma Inc

Methods of reducing the risk of a cardiovascular event in a subject on statin therapy

In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, a method of reducing the risk of a cardiovascular event in a subject on statin therapy having a fasting baseline triglyceride level of about 135 mg/dl to about 500 mg/dl, and administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.. . ... Amarin Pharma Inc

Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids

In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of reducing or preventing sdldl oxidation in a subject, the method comprising administering to the subject a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.. . ... Amarin Pharma Inc

Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof

The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.. . ... Amarin Pharma Inc

Compositions and methods for treating and/or preventing cardiovascular disease

In various embodiments, the present invention provides pharmaceutical compositions comprising fatty acids and methods for treating subjects using same.. . ... Amarin Pharma Inc

Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy

In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof.. . ... Amarin Pharma Inc

05/11/17 / #20170128402

Stable pharmaceutical composition and methods of using same

The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.. . ... Amarin Pharma Inc

05/04/17 / #20170119723

Methods of reducing the risk of a cardiovascular event in a subject on statin therapy

In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, a method of reducing the risk of a cardiovascular event in a subject on statin therapy having a fasting baseline triglyceride level of about 135 mg/dl to about 500 mg/dl, and administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.. . ... Amarin Pharma Inc

05/04/17 / #20170119722

Methods of treating hypertriglyceridemia

In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.. . ... Amarin Pharma Inc

05/04/17 / #20170119721

Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof

The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.. . ... Amarin Pharma Inc

03/30/17 / #20170087111

Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids

In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of reducing or preventing small dense ldl (“sdldl”) oxidation in a subject, the method comprising administering to the subject a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.. . ... Amarin Pharma Inc

03/02/17 / #20170056361

Methods of reducing the risk of a cardiovascular event in a subject on statin therapy

In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, a method of reducing the risk of a cardiovascular event in a subject on statin therapy having a fasting baseline triglyceride level of about 135 mg/dl to about 500 mg/dl, and administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.. . ... Amarin Pharma Inc

02/09/17 / #20170035722

Methods of reducing the risk of a cardiovascular event in a subject on statin therapy

In various embodiments, the present invention provides methods of reducing the risk of a cardiovascular event in a subject on statin therapy and, in particular, a method of reducing the risk of a cardiovascular event in a subject on statin therapy having a fasting baseline triglyceride level of about 135 mg/dl to about 500 mg/dl, and administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of eicosapentaenoic acid ethyl ester or a derivative thereof.. . ... Amarin Pharma Inc

01/19/17 / #20170014366

Methods of treating mixed dyslipidemia

The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with ethyl eicosapentaenoate.. . ... Amarin Pharma Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Amarin Pharma Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Amarin Pharma Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###